NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and CFO Glenn Goddard sold $158K of Intellia Therapeutics, Inc.
Sold$158,053
$29.46Price
5,365Shares
−12%Stake
What NTLA did after the filing
- The stock from Fri, Jan 5 close, $28.63
- −5.2%
- S&P 500, same days
- +6.2%
Measured over 30 trading days, to the Feb 20 close.
Traded Wed, Jan 3. Filed Fri, Jan 5, 11:49 AM ET, during the session. Returns use the Jan 5 close and the Feb 20 close. Not investment advice.